We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Improved Stent for Biliary Blockage

By HospiMedica staff writers
Posted on 12 Sep 2002
A new self-expanding, crush-recoverable stent is designed to treat biliary obstructions, a life-threatening condition.

The stent's delivery system has two built-in mechanisms to help reduce unintentional stent movement during deployment. More...
One enables doctors to advance the stent, gradually allowing for a more-controlled deployment. The second allows doctors to deploy the stent in one smooth, controlled motion. The stent is laser-cut from Nitinol, an alloy of nickel and titanium that provides shape-memory properties for easy, predictable placement. Called the Smart Control Stent, the device is the product of Cordis Endovascular (Warren, NJ, USA).

"Last year, we greatly improved the ability to visualize the stent during predeployment, initial stent release, and postdeployment by launching the Smart Transhepatic Biliary Stent with Micro Marker technology,” said Carol L. Zilm, president of Cordis Endovascular, a Johnson & Johnson company. "Now, we have the third generation of this product line, giving physicians the ability to single-handedly experience a more controlled delivery.”





Related Links:
Cordis Enodvascular

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.